$337M | ||
$259M | ||
$100M | ||
$79M | ||
$60M | ||
$58M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
Over the last 12 months, insiders at ProPhase Labs, Inc. have bought $0 and sold $0 worth of ProPhase Labs, Inc. stock.
On average, over the past 5 years, insiders at ProPhase Labs, Inc. have bought $157,047 and sold $137,500 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 721 shares for transaction amount of $4,672 was made by Barr Jason Michael (director) on 2022‑03‑10.
2022-03-10 | Barr Jason Michael | director | 721 0.0046% | $6.48 | $4,672 | +59.75% | ||
2021-06-03 | Karkus Ted William | CEO & CHAIRMAN | 33,943 0.2283% | $5.07 | $171,921 | +35.81% | ||
2020-08-13 | Sale | Karkus Ted William | CEO & CHAIRMAN | 50,000 0.4309% | $2.75 | $137,500 | +144.21% | |
2020-08-13 | GLECKEL LOUIS MD | director | 50,000 0.4309% | $2.75 | $137,500 | +144.21% | ||
2020-03-26 | Sale | Karkus Ted William | CEO & CHAIRMAN | 100,000 0.8634% | $1.75 | $175,000 | -1.63% | |
2020-03-26 | GLECKEL LOUIS MD | director | 100,000 0.8634% | $1.75 | $175,000 | -1.63% | ||
2019-10-01 | Barr Jason Michael | director | 2,870 0.0247% | $1.96 | $5,625 | -2.61% | ||
2019-08-15 | Barr Jason Michael | director | 2,500 0.0226% | $2.05 | $5,125 | -0.33% | ||
2019-08-14 | Barr Jason Michael | director | 6,000 0.0516% | $2.05 | $12,300 | -4.53% | ||
2017-12-21 | Sale | Karkus Ted William | CEO & CHAIRMAN | 424,789 2.8532% | $2.30 | $977,015 | +82.05% | |
2017-09-29 | Sale | Karkus Ted William | CEO & CHAIRMAN | 364,950 2.4565% | $2.30 | $839,385 | +35.68% | |
2017-09-29 | Sale | Leonard Braden Michael | 10 percent owner | 1.7M 11.4114% | $2.30 | $3.9M | +35.68% | |
2017-09-29 | Sale | CUDDIHY ROBERT V JR | Chief Financial Officer | 358,621 2.4139% | $2.30 | $824,828 | +35.68% | |
2017-09-29 | Sale | Barr Jason Michael | director | 4,379 0.0295% | $2.30 | $10,072 | +35.68% | |
2015-11-30 | Leventhal Mark S | director | 948 0.0059% | $1.48 | $1,403 | -2.60% | ||
2015-11-27 | Leventhal Mark S | director | 13,300 0.0838% | $1.55 | $20,615 | -5.66% | ||
2015-11-25 | Leventhal Mark S | director | 17,252 0.0956% | $1.30 | $22,428 | -1.32% | ||
2015-11-24 | Leventhal Mark S | director | 18,500 0.1111% | $1.30 | $24,050 | +7.14% | ||
2015-06-04 | Karkus Ted William | See Remarks | 200,000 1.2581% | $1.30 | $260,000 | +8.03% | ||
2015-05-19 | Karkus Ted William | CEO & Chairman | 399,008 2.5865% | $1.35 | $538,661 | +6.52% |
QUIGLEY GUY J | 10 percent owner | 2581559 6.2145% | $960,339.95 | 0 | 5 | |
Karkus Ted William | CEO & CHAIRMAN | 2333471 5.6172% | $868,051.21 | 11 | 4 | +11.6% |
PHILLIPS CHARLES A | EVP, COO | 1011706 2.4354% | $376,354.63 | 0 | 4 | |
Leventhal Mark S | director | 881980 2.1231% | $328,096.56 | 8 | 0 | +8.87% |
Leonard Braden Michael | 10 percent owner | 627322 1.5101% | $233,363.78 | 14 | 1 | <0.0001% |
Burnett Mark A. | director | 301768 0.7264% | $112,257.70 | 2 | 0 | |
GLECKEL LOUIS MD | director | 273840 0.6592% | $101,868.48 | 2 | 0 | +71.29% |
CUDDIHY ROBERT V JR | Chief Financial Officer | 132703 0.3194% | $49,365.52 | 0 | 1 | |
Frank Mark Shawn | director | 70195 0.169% | $26,112.54 | 1 | 0 | +13.69% |
Barr Jason Michael | director | 30962 0.0745% | $11,517.86 | 4 | 1 | +59.75% |
MCCUBBIN JAMES T | director | 25937 0.0624% | $9,648.56 | 1 | 0 | 0% |
SCHAUM ROUNSEVELLE W | director | 0 0% | $0 | 0 | 9 |
$2,051,022 | 1591 | -12.84% | $58.05M | |
$22,899,264 | 81 | 34.90% | $17.46M | |
$218,350,131 | 64 | 16.68% | $221.98M | |
$125,860,243 | 57 | -4.48% | $36.57M | |
$2,740,482 | 50 | 9.37% | $29.66M | |
$30,209,812 | 45 | -1.91% | $13.31M | |
ProPhase Labs, Inc. (PRPH) | $3,140,759 | 30 | 10.79% | $15.45M |
$423,174,478 | 29 | -7.58% | $38.46M | |
$32,539,771 | 28 | 33.37% | $230.33M | |
$25,034,841 | 20 | 9.38% | $119.7M | |
$934,616 | 12 | 74.76% | $8.2M | |
$758,061 | 9 | 60.03% | $167.73M | |
$4,039,981 | 8 | -3.44% | $13.18M | |
$8,171,353 | 7 | -14.29% | $14.31M | |
$138,873 | 5 | 1.23% | $65.14M | |
$15,894 | 5 | -31.45% | $8.82M | |
$5,003,136 | 1 | -14.58% | $284.35M | |
$999,999 | 1 | -52.42% | $14.43M | |
$10,000 | 1 | -96.58% | $6.93M |
Increased Positions | 19 | +54.29% | 3M | +116.02% |
Decreased Positions | 13 | -37.14% | 500,910 | -20.71% |
New Positions | 11 | New | 3M | New |
Sold Out Positions | 5 | Sold Out | 182,856 | Sold Out |
Total Postitions | 41 | +17.14% | 5M | +95.31% |
Vanguard Group Inc | $217.00 | 1.56% | 655,032 | -915 | -0.14% | 2024-12-31 |
Renaissance Technologies Llc | $95.00 | 0.68% | 286,485 | +71,375 | +33.18% | 2024-12-31 |
Hightower Advisors, Llc | $78.00 | 0.56% | 236,781 | +57,736 | +32.25% | 2024-12-31 |
Sheets Smith Wealth Management | $69.00 | 0.5% | 208,300 | 0 | 0% | 2025-03-31 |
Geode Capital Management, Llc | $67.00 | 0.49% | 203,528 | +42,793 | +26.62% | 2024-12-31 |
Perritt Capital Management Inc | $63.00 | 0.45% | 190,000 | +107,068 | +129.1% | 2024-12-31 |
Warberg Asset Management Llc | $34.00 | 0.24% | 101,672 | +101,672 | New | 2024-12-31 |
Cerity Partners Llc | $31.00 | 0.22% | 94,113 | +94,113 | New | 2025-03-31 |
Chapin Davis, Inc. | $26.00 | 0.19% | 80,000 | +30,000 | +60% | 2025-03-31 |
Blackrock, Inc. | $23.00 | 0.16% | 68,859 | -783 | -1.12% | 2025-03-31 |